APAF Adopts Nonlinear's SameSpots Approach
News Apr 20, 2006
Nonlinear Dynamics Ltd has announced that the Australian Proteome Analysis Facility Ltd. (APAF) has adopted Nonlinear's SameSpots approach to 2D gel image analysis, by investing in TT900 S2S used with their installed Progenesis PG240 software.
Nonlinear claims that, the SameSpots approach achieves 100% matching across any size experiment with no missing values within the data. The ability to generate a completely matched experiment delivers 2D proteomics data with real statistical power.
This translates into major improvements in the quality and reliability of analysis results.
Professor Mark Baker, CEO of the Australian Proteome Analysis Facility, said, "TT900 S2S with SameSpots delivers an alternative starting point for 2D image analysis - offering significant improvements in image matching."
"The benefit of reliably matching spots across all gel images from the start means you can quickly focus your research efforts on investigating the few spots showing statistically valid changes, which are indicative of potentially interesting expression profiling changes."
Mark Bennett, General Manager of Nonlinear Dynamics' US and Pacific Rim operations, said, "APAF has a reputation as one of the worlds leading proteomics research facilities."
"We are therefore delighted they have underlined their confidence in Nonlinear's analysis solutions through their purchase of TT900 S2S and upgrading PG240 to enable SameSpots. This means the quality and reliability of their 2D results will be dramatically enhanced."
A team led by Johns Hopkins Medicine researchers says it has identified two protein biomarkers in urine that may one day be used to better diagnose acute interstitial nephritis, an underdiagnosed but treatable kidney disorder that impairs renal function in the short term and can lead to chronic kidney disease, permanent damage or renal failure if left unchecked.READ MORE